Early identification of interferon-beta responders by ex vivo testing in patients with multiple sclerosis

Interferon-beta (IFN-beta) is an effective treatment for a subgroup of patients with multiple sclerosis (MS). The mechanism of action as well as the pathophysiological basis of responsiveness to IFN-beta is not well understood. To improve treatment considerations in MS patients predictive markers fo...

Description complète

Détails bibliographiques

Publié dans:	Clinical immunology (Orlando, Fla.). - 1999. - 128(2008), 3 vom: 01. Sept., Seite 306-13
Auteur principal:	Wiesemann, Elke (Auteur)
Autres auteurs:	Deb, Milani, Hemmer, Bernhard, Radeke, Heinfried H, Windhagen, Anja
Format:	Article en ligne
Langue:	English
Publié:	2008
Accès à la collection:	Clinical immunology (Orlando, Fla.)
Sujets:	Journal Article Research Support, Non-U.S. Gov't Antigens, CD B7-2 Antigen CD40 Antigens Cytokines Intercellular Signaling Peptides and Proteins PDCD1LG2 protein, human Programmed Cell Death 1 Ligand 2 Protein Interleukin-10 plus... 130068-27-8 Interferon-beta 77238-31-4